Real-world treatment patterns of palbociclib and blood count monitoring in patients with advanced breast cancer in Japan (vol 18, pg 2101, 2022)

被引：0
|
作者：
Sawaki, Masataka
Muramatsu, Yasuaki
Togo, Kanae
Laurent, Thomas
Iwata, Hiroji
机构：
来源：
FUTURE ONCOLOGY | 2023年
关键词：
D O I：
10.2217/fon-2021-1448c1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real-world PARPi treatment patterns and outcomes among patients with metastatic breast cancer.
    Dawood, Shaheenah S.
    Brzozowski, Kaylen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Real-World Treatment Patterns in Patients with Vitiligo in the United States (vol 13, pg 2079, 2023)
    Rosmarin, David
    Soliman, Ahmed M.
    Li, Chao
    DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2925 - 2925
  • [43] Real-world treatment of niraparib as maintenance therapy in patients newly diagnosed advanced ovarian cancer in Japan
    Shimada, Muneaki
    Kuwahara, Yuki
    Kuwabara, Hiroyo
    Kato, Ai
    Tabata, Tsutomu
    ANNALS OF ONCOLOGY, 2023, 34 : S1440 - S1440
  • [44] Real-world palbociclib dosing patterns and implications for drug costs in the treatment of HR+/HER2-metastatic breast cancer
    Li, Nanxin
    Du, Ella X.
    Chu, Lihao
    Peeples, Miranda
    Xie, Jipan
    Barghout, Victoria
    Tang, Derek H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (12) : 1167 - 1178
  • [45] Real-world advanced gastric cancer treatment patterns in Western and Asian countries
    Rha, S. Y.
    Calvo, E.
    Contente, M.
    Rider, A.
    Maglinte, G.
    Clarke, B.
    Muro, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study
    Joanne L. Blum
    Caroline DiCristo
    David Gordon
    Meghan S. Karuturi
    David Oubre
    Erin Jepsen
    Juan Cuevas
    Shailendra Lakhanpal
    Monica Z. Montelongo
    Zhe Zhang
    Joseph C. Cappelleri
    Yao Wang
    Debu Tripathy
    Breast Cancer Research and Treatment, 2024, 203 : 463 - 475
  • [47] Outcomes of male patients with HR+/HER2-advanced breast cancer receiving palbociclib in the real-world POLARIS study
    Blum, Joanne L.
    Dicristo, Caroline
    Gordon, David
    Karuturi, Meghan S.
    Oubre, David
    Jepsen, Erin
    Cuevas, Juan
    Lakhanpal, Shailendra
    Montelongo, Monica Z.
    Zhang, Zhe
    Cappelleri, Joseph C.
    Wang, Yao
    Tripathy, Debu
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (03) : 463 - 475
  • [48] Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy
    Bui, Tam Binh V.
    Burgers, Desiree M. T.
    Agterof, Mariette J.
    van de Garde, Ewoudt M. W.
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2019, 13
  • [49] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Varella, Leticia
    Eziokwu, Akaolisa Samuel
    Jia, Xuefei
    Kruse, Megan
    Moore, Halle C. F.
    Budd, George Thomas
    Abraham, Jame
    Montero, Alberto J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 429 - 434
  • [50] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Leticia Varella
    Akaolisa Samuel Eziokwu
    Xuefei Jia
    Megan Kruse
    Halle C. F. Moore
    George Thomas Budd
    Jame Abraham
    Alberto J. Montero
    Breast Cancer Research and Treatment, 2019, 176 : 429 - 434
12345